The Gujarat government will shortly launch the procurement procedure for the bulk drug park's common facilities and land allocation to the enterprises.

The 2,000-acre bulk medicine park will play a crucial role in ensuring domestic production of key starting materials (KSM), active pharmaceutical ingredients (API), and pharmaceutical intermediates, all of which are now imported from China.

As per Indian Drug Manufacturers' Association (IDMA) estimates, the park will have 400 companies and see an investment of over Rs 8,000 crore.

IDMA president Viranchi Shah said, "Gujarat is India's pharma hub with around 28 per cent share in exports and 32 per cent share in total production.”

Common facilities like nitrogen utility, Common Effluent Treatment Plant (CETP), solvent recovery, training facility, testing and research facility and common steam utility will be set up and tendering process will be started soon. We hope the common facilities will be set up by end of the current financial year,” he said.